NPI-3866

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNPI-3866
Drug Alias NameNPI-3866
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHSV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNereus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex Virus Type 2 InfectionsHerpes Simplex Virus Type 1 Infections

Other Information

ATC CodeN/A
Related LinksN/A